Cite

HARVARD Citation

    Majd, N. et al. (2019). Challenges and strategies for successful clinical development of immune checkpoint inhibitors in glioblastoma. Expert opinion on pharmacotherapy. pp. 1609-1624. [Online]. 
  
Back to record